Skip to main

Designation of Adalimumab (HUMIRA) as an Orphan Drug - AbbVie Pty Ltd

Administered by
  • Department of Health, Disability and Ageing

This item is authorised by the following title:

Latest version
C2012G0025514 November 2012

Legislation text